🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

30+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 10 of 30 recruiting trials for “familial-thrombocytosis”

Phase 2RecruitingNCT05467800 ↗

Study of Canakinumab in Patients With Myelofibrosis

👨‍⚕️ John Mascarenhas, MD, MOUNT SINAI HOSPITAL📍 8 sites📅 Started Aug 2022View details ↗
Phase 3RecruitingNCT05198960 ↗

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

🏥 University Hospital, Brest📍 42 sites📅 Started Jul 2022View details ↗
Phase 1, PHASE2RecruitingNCT05320198 ↗

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

👨‍⚕️ Will Savage, MD PhD, Disc Medicine📍 23 sites📅 Started Jun 2022View details ↗
RecruitingNCT06516406 ↗

Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera

🏥 IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 26 sites📅 Started May 2022View details ↗
Phase 2RecruitingNCT04644211 ↗

Ruxolitinib in Thrombocythemia and Polycythemia Vera

👨‍⚕️ Gabriela Hobbs, MD, Massachusetts General Hospital📍 4 sites📅 Started Mar 2022View details ↗
Phase 1, PHASE2RecruitingNCT05123365 ↗

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

👨‍⚕️ Angela Fleischman, MD, PhD, Chao Family Comprehensive Cancer Center📍 2 sites📅 Started Jan 2022View details ↗
NARecruitingNCT04942080 ↗

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

🏥 University Hospital, Angers📍 10 sites📅 Started Oct 2021View details ↗
Phase 2RecruitingNCT04226950 ↗

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia

👨‍⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Jan 2020View details ↗
RecruitingNCT02897297 ↗

Myeloproliferative Neoplastic Diseases Observatory From Brest

👨‍⚕️ Jean-Christophe Ianotto, CHRU de Brest📍 1 site📅 Started Sep 2015View details ↗
RecruitingNCT01257269 ↗

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

👨‍⚕️ Johanna A Kremer Hovinga, MD, University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital📍 7 sites📅 Started Oct 2006View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →